Surgery Websites
Breast Care Surgery »  Faculty »  Breast Care Surgeons »  Cheryl A. Ewing, M.D.
Cheryl A. Ewing, M.D.

Cheryl A. Ewing, M.D.

  • Professor of Surgery
  • Division of Surgical Oncology

Contact Information

Academic Office
415) 353-7908
(415) 353-9571
[email protected]
Open Popup
  • 1978-83, Wayne State University School of Medicine, MD
  • 1983-88, St. Joseph Mercy Hospital, University of Michigan Medical School
  • 1988-91, Surgical Oncology Fellow, University of Chicago
  • 1984, American Board of Surgery
  • 1998, American Board of Surgery
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • Ductal Carcinoma In Situ (DCIS)
  • Minority Health
  • Mastectomy
  • Sentinel Lymph Node Biopsy

Dr. Cheryl Ewing is Professor of Surgery at UCSF Health.  Her focus is in breast cancer surgery and sentinel lymph node dissection.  Her other interests include quality of care and evaluation of barriers to medical and breast care for minority women.  

Dr. Ewing completed her undergraduate education at the University of Michigan, and received her medical degree from Wayne State University School of Medicine.  She then went on to complete her residency at University of Michigan Medical School, and then her fellowship at the University of Chicago.  She joined the faculty at UCSF in 2001.

Dr. Ewing has lectured extensively at many local, national, and international events.  She has been very active in mentoring residents and fellows, serving four years as the Mount Zion Site Director for the Surgery 110 Rotations and teaching several CME courses and Grand Rounds.  

Dr. Ewing is involved in several studies involving quality of care among breast cancer survivors.  Specifically, these involve post-surgery symptom management, and customizing risk assessment and tailoring treatment to the individual patient's medical profile and preferences.  Her primary focus in on how being a breast cancer survivor affects the quality of life in different race/ethnic groups, and how that relationship is modified by social support, depression, and spirituality.

Dr. Ewing is a member of most of the major surgical societies, and has been the recipient of several awards, including the Susan G. Komen Local Hero Award.

MOST RECENT PUBLICATIONS FROM A TOTAL OF 59
Data provided by UCSF Profiles, powered by CTSI
  1. Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas C, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar R. ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years-Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial. Ann Surg Oncol. 2023 10; 30(11):6411-6412. View in PubMed
  2. Rothschild HT, Clelland EN, Mujir F, Record H, Wong J, Esserman LJ, Alvarado M, Ewing C, Mukhtar RA. ASO Visual Abstract: Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy. Ann Surg Oncol. 2023 Oct; 30(10):6007. View in PubMed
  3. Rothschild HT, Clelland EN, Mujir F, Record H, Wong J, Esserman LJ, Alvarado M, Ewing C, Mukhtar RA. Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy. Ann Surg Oncol. 2023 Oct; 30(10):5999-6006. View in PubMed
  4. Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar RA. Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial. Ann Surg Oncol. 2023 Oct; 30(11):6401-6410. View in PubMed
  5. Mukhtar RA, Chau H, Woriax H, Piltin M, Ahrendt G, Tchou J, Yu H, Ding Q, Dugan CL, Sheade J, Crown A, Carr M, Wong J, Son J, Yang R, Chan T, Terando A, Alvarado M, Ewing C, Tonneson J, Tamirisa N, Gould R, Singh P, Godellas C, Larson K, Chiba A, Rao R, Sauder C, Postlewait L, Lee MC, Symmans WF, Esserman LJ, Boughey JC, ISPY-2 Locoregional Working Group. Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial. Ann Surg. 2023 09 01; 278(3):320-327. View in PubMed
  6. View All Publications

 

Site Directory
    X